High phosphate directly affects endothelial function by downregulating annexin II

Kidney International

Volumn 83, Issue 2, 2013, Pages 213-222

  Di Marco, Giovana Seno ^a   König, Maximilian ^a   Stock, Christian ^a   Wiesinger, Anne ^a   Hillebrand, Uta ^a   Reiermann, Stefanie ^a   Reuter, Stefan ^a   Amler, Susanne ^a   Köhler, Gabriele ^b   Buck, Friedrich ^c   Fobker, Manfred ^a   Kümpers, Philipp ^a   Oberleithner, Hans ^a   Hausberg, Martin ^d   Lang, Detlef ^a,e   Pavenstädt, Hermann ^a   Brand, Marcus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d Karlsruhe General Hospital   (Germany)

^e Dialysis Center Nordhorn   (Germany)

Author keywords

angiogenesis; annexin II; chronic kidney disease; endothelial cells; hyperphosphatemia

Indexed keywords

LIPOCORTIN 2; PHOSPHATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CAPILLARY TUBE; CELL FUNCTION; CELL SURVIVAL; CHORIOALLANTOIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOTHELIAL FUNCTION; ENDOTHELIAL MICROPARTICLE; HUMAN; HUMAN CELL; HYPERPHOSPHATEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MIGRATION INHIBITION; NONHUMAN; PARTICLE SIZE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT;

EID: 84873410543     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.300     Document Type: Article

References (42)

1. Kestenbaum B. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin Dial 2007; 20: 286-294.
2. Voormolen N, Noordzij M, Grootendorst DC et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916.
3. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
4. Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885.
5. Foley RN. Phosphate levels and cardiovascular disease in the general population. Clin J Am Soc Nephrol 2009; 4: 1136-1139.
6. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
7. Tonelli M, Sacks F, Pfeffer M et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633.
8. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528.
9. Onufrak SJ, Bellasi A, Shaw LJ et al. Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 2008; 199: 424-431.
10. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32.
11. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14: S300-S304.
12. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
13. Di Marco GS, Hausberg M, Hillebrand U et al. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. Am J Physiol Renal Physiol 2008; 294: F1381-F1387.
14. Shuto E, Taketani Y, Tanaka R et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009; 20: 1504-1512.
15. Peng A, Wu T, Zeng C et al. Adverse effects of simulated hyper-and hypo-phosphatemia on endothelial cell function and viability. PLoS One 2011; 6: e23268.
16. Boulanger CM. Microparticles, vascular function and hypertension. Curr Opin Nephrol Hypertens 2010; 19: 177-180.
17. Koc M, Bihorac A, Segal MS. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. Am J Kidney Dis 2003; 42: 704-712.
18. Meijers BK, Van KS, Verbeke K et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901.
19. Siever DA, Erickson HP. Extracellular annexin II. Int J Biochem Cell Biol 1997; 29: 1219-1223.
20. Ling Q, Jacovina AT, Deora A et al. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 2004; 113: 38-48.
21. Su SC, Maxwell SA, Bayless KJ. Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. J Biol Chem 2010; 285: 40624-40634.
22. Lima e Silva R, Shen J, Gong YY et al. Agents that bind annexin A2 suppress ocular neovascularization. J Cell Physiol 2010; 225: 855-864.
23. Sharma MC, Sharma M. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 2007; 13: 3568-3575.
24. Somanath PR, Chen J, Byzova TV. Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis 2008; 11: 277-288.
25. Amann K, Ritz E. Microvascular disease-the Cinderella of uraemic heart disease. Nephrol Dial Transplant 2000; 15: 1493-1503.
26. Amann K, Tyralla K. Cardiovascular changes in chronic renal failure-pathogenesis and therapy. Clin Nephrol 2002; 58(Suppl 1): S62-S72.
27. Jacobi J, Porst M, Cordasic N et al. Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats. Kidney Int 2006; 69: 2013-2021.
28. Kang DH, Joly AH, Oh SW et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12: 1434-1447.
29. Carbo C, Arderiu G, Escolar G et al. Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum. Am J Kidney Dis 2008; 51: 603-612.
30. VanWijk MJ, VanBavel E, Sturk A et al. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277-287.
31. Banfi C, Brioschi M, Wait R et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005; 5: 4443-4455.
32. Chironi GN, Boulanger CM, Simon A et al. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143-151.
33. Mezentsev A, Merks RM, O'Riordan E et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005; 289: H1106-H1114.
34. Sharma MR, Rothman V, Tuszynski GP et al. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action. Exp Mol Pathol 2006; 81: 136-145.
35. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002; 90: 1243-1250.
36. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
37. Thang OH, Serne EH, Grooteman MP et al. Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels. Nephrol Dial Transplant 2011; 26: 3529-3536.
38. Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol 2009; 29: 761-766.
39. Abid Hussein MN, Boing AN, Sturk A et al. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007; 98: 1096-1107.
40. Kliche K, Jeggle P, Pavenstadt H et al. Role of cellular mechanics in the function and life span of vascular endothelium. Pflugers Arch 2011; 462: 209-217.
41. Kusche-Vihrog K, Urbanova K, Blanque A et al. C-reactive protein makes human endothelium stiff and tight. Hypertension 2011; 57: 231-237.
42. Dimmeler S, Fleming I, Fisslthaler B et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.